Trending Stock News

Tcs Capital Management Has Cut Holding in Angies List (ANGI) by $5.77 Million as Market Value Rose; Alphamark Advisors Cut Its Holding in Enanta Pharmaceutical (ENTA) by $345,000 as Market Valuation Rose

Alphamark Advisors Llc decreased its stake in Enanta Pharmaceutical (ENTA) by 22.73% based on its latest 2017Q3 regulatory filing with the SEC. Alphamark Advisors Llc sold 7,500 shares as the company’s stock rose 11.35% with the market. The institutional investor held 25,500 shares of the health care company at the end of 2017Q3, valued at $1.19 million, down from 33,000 at the end of the previous reported quarter. Alphamark Advisors Llc who had been investing in Enanta Pharmaceutical for a number of months, seems to be less bullish one the $1.26 billion market cap company. The stock increased 0.33% or $0.22 during the last trading session, reaching $66. About 168,486 shares traded. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has risen 40.91% since January 18, 2017 and is uptrending. It has outperformed by 24.21% the S&P500.

Eric Semler decreased its stake in Angies List Inc (ANGI) by 8.13% based on its latest 2017Q3 regulatory filing with the SEC. Tcs Capital Management Llc sold 481,178 shares as the company’s stock rose 95.14% with the market. The hedge fund run by Eric Semler held 5.43 million shares of the consumer services company at the end of 2017Q3, valued at $67.71 million, down from 5.92 million at the end of the previous reported quarter. Tcs Capital Management Llc who had been investing in Angies List Inc for a number of months, seems to be less bullish one the $6.26B market cap company. The stock increased 0.46% or $0.06 during the last trading session, reaching $13.11. About 1.20 million shares traded or 123.79% up from the average. ANGI Homeservices Inc. (NASDAQ:ANGI) has risen 32.08% since January 18, 2017 and is uptrending. It has outperformed by 15.38% the S&P500.

Among 11 analysts covering Angie’s List (NASDAQ:ANGI), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. Angie’s List had 19 analyst reports since July 23, 2015 according to SRatingsIntel. Piper Jaffray initiated ANGI Homeservices Inc. (NASDAQ:ANGI) on Wednesday, August 16 with “Buy” rating. The rating was upgraded by Raymond James to “Outperform” on Friday, August 19. RBC Capital Markets maintained the shares of ANGI in report on Thursday, July 23 with “Sector Perform” rating. The rating was initiated by Goldman Sachs on Wednesday, October 11 with “Buy”. The rating was maintained by Oppenheimer on Wednesday, January 3 with “Buy”. The company was maintained on Wednesday, July 26 by Wells Fargo. The company was maintained on Thursday, October 22 by RBC Capital Markets. The rating was maintained by M Partners with “Neutral” on Thursday, December 31. The firm has “Hold” rating by Loop Capital given on Tuesday, May 2. The rating was maintained by Oppenheimer with “Buy” on Friday, November 10.

Investors sentiment decreased to 0.58 in Q3 2017. Its down 0.79, from 1.37 in 2017Q2. It worsened, as 32 investors sold ANGI shares while 20 reduced holdings. 19 funds opened positions while 11 raised stakes. 39.58 million shares or 20.91% less from 50.04 million shares in 2017Q2 were reported. Moreover, Hudson Bay Capital Mgmt LP has 0.11% invested in ANGI Homeservices Inc. (NASDAQ:ANGI) for 369,660 shares. Credit Suisse Ag owns 0% invested in ANGI Homeservices Inc. (NASDAQ:ANGI) for 48,641 shares. 607,595 were reported by Dimensional Fund Advsrs Ltd Partnership. State Bank Of Ny Mellon Corporation reported 0% of its portfolio in ANGI Homeservices Inc. (NASDAQ:ANGI). Nationwide Fund Advsrs reported 0% stake. Invesco Limited invested 0% in ANGI Homeservices Inc. (NASDAQ:ANGI). State Board Of Administration Of Florida Retirement System holds 0% or 45,153 shares in its portfolio. Price T Rowe Assoc Md owns 8.44M shares. 5.52M are owned by Morgan Stanley. Victory Cap, Ohio-based fund reported 109,980 shares. Citigroup holds 0% in ANGI Homeservices Inc. (NASDAQ:ANGI) or 127 shares. 170,000 were reported by Scopus Asset Lp. Jane Street Gru reported 0% in ANGI Homeservices Inc. (NASDAQ:ANGI). Rwc Asset Management Limited Liability Partnership invested in 500,000 shares or 0.38% of the stock. Bankshares Of Montreal Can has 0% invested in ANGI Homeservices Inc. (NASDAQ:ANGI).

Since July 31, 2017, it had 0 insider buys, and 6 insider sales for $8.31 million activity. HOWELL J MARK sold $1.57M worth of stock or 134,901 shares. $1.05M worth of ANGI Homeservices Inc. (NASDAQ:ANGI) shares were sold by Shaw Shannon. Hicks Bowman Angela R. had sold 300,000 shares worth $3.59 million on Monday, July 31.

Analysts await ANGI Homeservices Inc. (NASDAQ:ANGI) to report earnings on February, 21. They expect $-0.03 earnings per share, down 120.00% or $0.18 from last year’s $0.15 per share. After $-0.17 actual earnings per share reported by ANGI Homeservices Inc. for the previous quarter, Wall Street now forecasts -82.35% EPS growth.

Alphamark Advisors Llc, which manages about $314.05 million and $235.94 million US Long portfolio, upped its stake in Pimco Enhanced Sht Mat (MINT) by 3,500 shares to 15,275 shares, valued at $1.56M in 2017Q3, according to the filing. It also increased its holding in Digital Realty Trust (NYSE:DLR) by 8,217 shares in the quarter, for a total of 8,837 shares, and has risen its stake in Ishares Ibonds Dec 201.

Analysts await Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) to report earnings on February, 14. They expect $0.04 earnings per share, up 115.38% or $0.30 from last year’s $-0.26 per share. ENTA’s profit will be $764,848 for 412.50 P/E if the $0.04 EPS becomes a reality. After $1.86 actual earnings per share reported by Enanta Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -97.85% negative EPS growth.

Among 5 analysts covering Enanta Pharmaceuticals Inc (NASDAQ:ENTA), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Enanta Pharmaceuticals Inc had 20 analyst reports since August 7, 2015 according to SRatingsIntel. Robert W. Baird maintained it with “Neutral” rating and $36 target in Tuesday, August 8 report. The firm earned “Overweight” rating on Tuesday, August 9 by JP Morgan. Robert W. Baird maintained it with “Hold” rating and $46.0 target in Monday, November 20 report. The company was maintained on Friday, October 20 by RBC Capital Markets. The stock of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has “Buy” rating given on Saturday, August 8 by TheStreet. JMP Securities upgraded the shares of ENTA in report on Tuesday, July 11 to “Market Outperform” rating. The stock of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has “Hold” rating given on Friday, September 15 by Robert W. Baird. On Tuesday, January 2 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. The rating was maintained by Robert W. Baird with “Hold” on Friday, October 20. On Friday, October 23 the stock rating was upgraded by JMP Securities to “Mkt Outperform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *